Head-to-Head Comparison
OpenEvidence vs Glass Health: Which Is Better for Physicians?
OpenEvidence: AI Research Assistant for Evidence-Based Clinical Decisions Glass Health: Clinical Questions, Ambient Scribing, and Clinical Planning
Updated
Direct Answer
Source: Clinical AI Report, 2026
Key takeaways
- OpenEvidence is free for verified US clinicians, with labeled ads, and draws on content partnerships with NEJM, JAMA, NCCN, ACC, AAFP and ACEP.
- Glass Health offers a free, ad-supported Lite tier with usage limits and paid clinician plans at $20, $90 and $200 a month, checked October 7, 2026.
- OpenEvidence does not generate differential diagnoses or offer drug dosing tools, while Glass Health documents differential diagnosis support and assessment-and-plan drafting with cited evidence.
- Glass Health lists supported EHR workflows for Epic, eClinicalWorks, athenahealth and Elation on its Max plan; OpenEvidence’s EHR integration is early-stage.
Feature Comparison
| Feature | OpenEvidence | Glass Health |
|---|---|---|
| Rating | OpenEvidence: Good | Glass Health: Good |
| Category | OpenEvidence: AI Medical Research Assistant | Glass Health: Clinical Decision Support and Ambient Scribing |
| Pricing | OpenEvidence: Free (Ad-Supported) | Glass Health: Lite free; paid plans $20–$200/month (USD) |
| Founded | OpenEvidence: 2022 | Glass Health: 2021 |
| Headquarters | OpenEvidence: Miami, FL | Glass Health: San Francisco, CA |
| Evidence Citations | OpenEvidence: Yes | Glass Health: No |
| AI Differential Diagnosis | OpenEvidence: No | Glass Health: Yes |
| Drug Database | OpenEvidence: No | Glass Health: No |
| Drug Interaction Checker | OpenEvidence: No | Glass Health: No |
| Medical Calculators | OpenEvidence: Yes | Glass Health: No |
| Natural Language Search | OpenEvidence: Yes | Glass Health: No |
| Document & Image Upload | OpenEvidence: No | Glass Health: Yes |
| EHR Integration | OpenEvidence: Yes | Glass Health: Yes |
| Mobile App | OpenEvidence: Yes | Glass Health: No |
| Built-in Dialer | OpenEvidence: Yes | Glass Health: No |
| AI Clinical Scribe | OpenEvidence: No | Glass Health: No |
| CME Credits | OpenEvidence: No | Glass Health: No |
| Multi-Language | OpenEvidence: Yes | Glass Health: No |
Strengths & Limitations
OpenEvidence
Strengths
- +Useful for generalist clinical questions — fast, cited answers for everyday practice
- +Widely adopted clinical AI in the US (757K+ physicians)
- +Free for all verified physicians
- +Broadest content partnership network: NEJM, JAMA (all 11 specialty journals), NCCN, ACC, AAFP, ACEP, ADA, AAOS, 300+ journals
- +Native iOS and Android apps with Home Screen widgets
- +Quick Consult and Deep Consult modes for different clinical needs
- +Built-in dialer for calling patients, pharmacies, and colleagues
- +Well-funded with strong investor backing ($12B valuation, $100M annual revenue)
Limitations
- –No differential diagnosis generation or drug dosing tools
- –Ad-supported revenue model (pharmaceutical/healthcare advertising)
- –EHR integration is early-stage (Sutter Health/Epic announced February 2026)
- –Preprint by Jagarapu et al. (2025) reported 41% accuracy on complex subspecialty scenarios
- –Clinical depth narrower than platforms with drug databases and medical calculators
Glass Health
Strengths
- +Documents ambient scribing and clinical decision support in one workflow
- +Provides references for users to inspect alongside generated answers
- +Offers a free Lite tier and publicly priced clinician subscriptions
- +Lists an iPhone/iPad app and supported EHR workflows
Limitations
- –EHR access and chart-data scope require setup confirmation
- –Plan capacity and model access vary; check current usage allowances
- –Citations and drafts still require clinician review
- –No independent accuracy or time-saving test was performed for this refresh
Key Statistics
OpenEvidence
Glass Health
Citable Summaries
OpenEvidence
OpenEvidence has an editorial score of 73/100 (3.7/5), calculated from Clinical AI Report's published criteria weights. It ranks #2 among 7 general clinical decision support tools under this rubric. The score is an editorial assessment, not an aggregate of user reviews or a clinical performance benchmark.
Source: Clinical AI Report, May 2026
Glass Health
Glass Health documents ambient scribing, cited clinical questions, and clinical plan drafting in one workflow; the appropriate plan depends on usage and deployment needs.
Source: Clinical AI Report, May 2026
Our Assessment
In our 2026 evaluation, OpenEvidence (ranked #2, 3.7 stars) outperforms Glass Health (ranked #5, 3.5 stars) in overall physician satisfaction and editorial scoring. OpenEvidence is best suited for a useful tool for physicians who need fast, cited answers to clinical questions grounded in peer-reviewed literature. Relevant for primary care, internal medicine, and emergency medicine. Free and backed by a broad content partnership network (NEJM, JAMA, NCCN, ACC, AAFP, ACEP). Meanwhile, Glass Health is a stronger choice for clinicians evaluating a combined documentation and clinical-question workflow, with source review and deployment requirements checked for their setting Both tools serve important but distinct roles in clinical care workflows, and physicians should choose based on their specific workflow requirements and institutional needs.